A question of balance or blind faith?: Scientists' and science policymakers' representations of the benefits and risks of nanotechnologies [Book Review]
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jonathan Jenkins Ichikawa
Jack Alan Reynolds
Learn more about PhilPapers
NanoEthics 1 (3):243-256 (2007)
In recent years, in the UK and elsewhere, scientists and science policymakers have grappled with the question of how to reap the benefits of nanotechnologies while minimising the risks. Having recognised the importance of public support for future innovations, they have placed increasing emphasis on ‘engaging’ ‘the public’ during the early phase of technology development. Meaningful engagement suggests some common ground between experts and lay publics in relation to the definition of nanotechnologies and of their benefits and risks. However, views on nanotechnologies are likely to vary according to where actors stand in the technology production/consumption/assessment cycle. Drawing on data from a recent UK-based study, this article examines how scientists (‘upstream’ and ‘downstream’) and policymakers portray the benefits and risks of nanotechnologies, particularly as they relate to two major areas of predicted application, namely medicine/public health and environmental sustainability. The findings reveal that, in the main, scientists and science policymakers held a positive conception of nanotechnologies and see imminent applications, although they acknowledged particular risks, including adverse public reaction. While definitions of ‘benefit’ and ‘risk’ varied, most saw the benefits as outweighing the risks and believed that the risks could be adequately regulated once they were assessed. The difficulties of assessing risk, however, were acknowledged. The study raises a number of questions that will need to be addressed if regulations are to be developed that not only protect people’s heath and wellbeing and the environment but also engender public trust in nanotechnologies.
|Keywords||Nanoparticles Scientists Science policymakers Risk Regulation Trust Public engagement Medicine Public health Environmental sustainability|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Alan Irwin (2003). Science, Social Theory and Public Knowledge. Open University Press.
Theodore L. Brown (2008). Making Truth: Metaphor in Science. University of Illinois Press.
Thomas F. Gieryn (1999). Cultural Boundaries of Science Credibility on the Line. Monograph Collection (Matt - Pseudo).
Brian E. Wynne, Public Engagement as Means of Restoring Trust in Science? Hitting the Notes, but Missing the Music.
Citations of this work BETA
Arianna Ferrari (2010). Developments in the Debate on Nanoethics: Traditional Approaches and the Need for New Kinds of Analysis. [REVIEW] NanoEthics 4 (1):27-52.
Céline Kermisch (2012). Do New Ethical Issues Arise at Each Stage of Nanotechnological Development? NanoEthics 6 (1):29-37.
Matthias Fink, Rainer Harms & Isabella Hatak (2012). Nanotechnology and Ethics: The Role of Regulation Versus Self-Commitment in Shaping Researchers' Behavior. [REVIEW] Journal of Business Ethics 109 (4):569-581.
Haico te Kulve, Kornelia Konrad, Carla Alvial Palavicino & Bart Walhout (2013). Context Matters: Promises and Concerns Regarding Nanotechnologies for Water and Food Applications. [REVIEW] NanoEthics 7 (1):17-27.
Stephen H. Cutcliffe, Christine M. Pense & Michael Zvalaren (2012). Framing the Discussion: Nanotechnology and the Social Construction of Technology--What STS Scholars Are Saying. NanoEthics 6 (2):81-99.
Similar books and articles
Annette Rid & David Wendler (2011). A Framework for Risk-Benefit Evaluations in Biomedical Research. Kennedy Institute of Ethics Journal 21 (2):141-179.
Joachim Schummer & Elena Pariotti (2008). Regulating Nanotechnologies: Risk Management Models and Nanomedicine. [REVIEW] NanoEthics 2 (1):39-42.
Janet Malek (2007). Understanding Risks and Benefits in Research on Reproductive Genetic Technologies. Journal of Medicine and Philosophy 32 (4):339 – 358.
Alfred Nordmann & Phil Macnaghten (2010). Engaging Narratives and the Limits of Lay Ethics: Introduction. [REVIEW] NanoEthics 4 (2):133-140.
Sven Ove Hansson (2004). Weighing Risks and Benefits. Topoi 23 (2):145-152.
Phil Macnaghten (2010). Engaging Narratives and the Limits of Lay Ethics: Introduction. [REVIEW] NanoEthics 4 (2):133-140.
Tee Rogers-Hayden, Alison Mohr & Nick Pidgeon (2007). Introduction: Engaging with Nanotechnologies – Engaging Differently? [REVIEW] NanoEthics 1 (2):123-130.
Noela Invernizzi (2008). Visions of Brazilian Scientists on Nanosciences and Nanotechnologies. NanoEthics 2 (2):133-148.
Regula Valérie Burri (2007). Deliberating Risks Under Uncertainty: Experience, Trust, and Attitudes in a Swiss Nanotechnology Stakeholder Discussion Group. NanoEthics 1 (2):143-154.
Alan Petersen (2009). Introduction: The Ethical Challenges of Nanotechnologies. [REVIEW] Journal of Bioethical Inquiry 6 (1):9-12.
Added to index2009-01-28
Total downloads14 ( #267,865 of 1,934,535 )
Recent downloads (6 months)3 ( #195,826 of 1,934,535 )
How can I increase my downloads?